• HHS on Friday released a report touting its 2017 accomplishments, including regulatory rollbacks and cost savings.
• The 37-page report highlighted some actions that are priorities for the Trump administration, but which have sharply divided the healthcare industry. It said 70 regulatory actions were withdrawn last year and more than $3 billion was recovered through efforts to stop waste, fraud and abuse.
• It also pointed to a final rule that cuts hospital payments from the 340B Drug Pricing Program, saying it will save $3.2 billion. Hospitals fiercely oppose the cut and are challenging the rule in court.

. . .